Nafithromycin-impurities | Pharmaffiliates

Nafithromycin

Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin in CABP). Reference standards of Nafithromycin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Nafithromycin - API standards
    [catalogue_number] => PA 14 1530000
    [category_ids] => ,69,70,78,82,91,
    [chemical_name] => 
    [weight] => 859.05
    [form] => C42H62N6O11S
    [cas] => 1691240-78-4
    [pslug] => 1691240-78-4-nafithromycin-api-standards-pa141530000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 14 1530000

Nafithromycin - API standards


  • Catalogue No.:PA 14 1530000

  • CAS :

    1691240-78-4

  • Molecular Formula : C42H62N6O11S

  • Molecular Weight : 859.05